• 1. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 2. Always a matter of interpretation: inferring student knowledge and understanding from research data
  Chem. Educ. Res. Pract., 2017,18, 7-12
• 3. Achieving molecular stability of racemic 4-O-benzyl-myo-inositol-1,3,5-orthoformate through crystal formation?
  Richa Sardessai,Shobhana Krishnaswamy,Mysore S. Shashidhar CrystEngComm, 2012,14, 8010-8016
• 4. An AuNPs-functionalized AlGaN/GaN high electron mobility transistor sensor for ultrasensitive detection of TNT?
  Ying Li,Weirong Yao,Yunfei Xie,Renjun Pei RSC Adv., 2015,5, 98724-98729
• 5. Agricultural
  Analyst, 1947,72, 170-172

Introduction to 5-Thiazolecarboxamide, 2-bromo-N-(1,1-dimethylethyl) (CAS No. 62435-94-3)

5-Thiazolecarboxamide, 2-bromo-N-(1,1-dimethylethyl), with the CAS number 62435-94-3, is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique thiazole ring structure and the presence of a bromine substituent and a tert-butyl amide group, which contribute to its diverse chemical properties and potential biological activities.

The thiazole ring, a five-membered heterocyclic compound containing sulfur and nitrogen atoms, is a common structural motif in many biologically active molecules. The presence of this ring in 5-Thiazolecarboxamide, 2-bromo-N-(1,1-dimethylethyl) imparts it with enhanced stability and reactivity, making it an attractive scaffold for the design of novel therapeutic agents. The bromine substituent at the 2-position of the thiazole ring further enhances the compound's electrophilic character, which can be exploited in various synthetic transformations and biological interactions.

The tert-butyl amide group in 5-Thiazolecarboxamide, 2-bromo-N-(1,1-dimethylethyl) provides additional steric hindrance and hydrophobicity, which can influence the compound's solubility and bioavailability. These properties are crucial for optimizing the pharmacokinetic profile of potential drug candidates. Recent studies have shown that compounds with similar structural features exhibit promising activities in various therapeutic areas, including anti-inflammatory, antimicrobial, and anticancer applications.

In the realm of medicinal chemistry, 5-Thiazolecarboxamide, 2-bromo-N-(1,1-dimethylethyl) has been investigated for its potential as a lead compound in drug discovery programs. One notable area of research is its use as an inhibitor of specific enzymes involved in disease pathways. For instance, thiazole derivatives have been shown to inhibit kinases and proteases, which are key targets in cancer therapy. The bromine substituent in this compound can facilitate interactions with specific amino acid residues in enzyme active sites, thereby enhancing its inhibitory activity.

Beyond its potential as a therapeutic agent, 5-Thiazolecarboxamide, 2-bromo-N-(1,1-dimethylethyl) has also been explored for its utility as a synthetic intermediate. The presence of the bromine atom makes it an excellent leaving group for various nucleophilic substitution reactions, allowing for the facile introduction of diverse functional groups. This versatility has led to its use in the synthesis of complex organic molecules and natural products.

In terms of safety and handling, it is important to note that while 5-Thiazolecarboxamide, 2-bromo-N-(1,1-dimethylethyl) is not classified as a hazardous material or controlled substance, standard laboratory safety protocols should be followed when working with this compound. Proper personal protective equipment (PPE) such as gloves and goggles should be worn to prevent skin contact and inhalation. Additionally, the compound should be stored in a cool, dry place away from incompatible materials.

The synthesis of 5-Thiazolecarboxamide, 2-bromo-N-(1,1-dimethylethyl) typically involves multistep procedures that include the formation of the thiazole ring followed by functional group modifications. One common approach involves the condensation of a thioamide with an appropriate aldehyde or ketone to form the thiazole ring. Subsequent bromination and amidation steps can then be used to introduce the desired substituents. Recent advancements in green chemistry have led to more environmentally friendly synthetic methods that minimize waste and reduce energy consumption.

In conclusion, 5-Thiazolecarboxamide, 2-bromo-N-(1,1-dimethylethyl) (CAS No. 62435-94-3) is a multifaceted compound with significant potential in both medicinal chemistry and synthetic organic chemistry. Its unique structural features make it an attractive candidate for further research and development as a therapeutic agent or synthetic intermediate. As ongoing studies continue to uncover new applications for this compound, it is likely to play an increasingly important role in advancing our understanding of chemical biology and drug discovery.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)